- Home
- TTAN vs HALO Comparison
TTAN vs HALO Comparison
Compare TTAN & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTAN
- HALO
- Stock Information
- Founded
- TTAN 2012
- HALO 1998
- Country
- TTAN United States
- HALO United States
- Employees
- TTAN N/A
- HALO N/A
- Industry
- TTAN
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TTAN
- HALO Health Care
- Exchange
- TTAN NYSE
- HALO Nasdaq
- Market Cap
- TTAN 10.2B
- HALO 7.4B
- IPO Year
- TTAN 2024
- HALO N/A
- Fundamental
- Price
- TTAN $129.26
- HALO $52.02
- Analyst Decision
- TTAN Buy
- HALO Buy
- Analyst Count
- TTAN 14
- HALO 9
- Target Price
- TTAN $118.23
- HALO $63.56
- AVG Volume (30 Days)
- TTAN 429.5K
- HALO 3.1M
- Earning Date
- TTAN 06-05-2025
- HALO 05-06-2025
- Dividend Yield
- TTAN N/A
- HALO N/A
- EPS Growth
- TTAN N/A
- HALO 55.40
- EPS
- TTAN N/A
- HALO 3.76
- Revenue
- TTAN $771,878,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- TTAN $19.04
- HALO $24.79
- Revenue Next Year
- TTAN $13.40
- HALO $22.65
- P/E Ratio
- TTAN N/A
- HALO $13.83
- Revenue Growth
- TTAN 25.64
- HALO 25.64
- 52 Week Low
- TTAN $79.81
- HALO $41.28
- 52 Week High
- TTAN $128.16
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- TTAN N/A
- HALO 39.78
- Support Level
- TTAN N/A
- HALO $47.50
- Resistance Level
- TTAN N/A
- HALO $69.94
- Average True Range (ATR)
- TTAN 0.00
- HALO 3.52
- MACD
- TTAN 0.00
- HALO -1.49
- Stochastic Oscillator
- TTAN 0.00
- HALO 19.64
About TTAN SERVICETITAN INC
ServiceTitan Inc is an end-to-end technology platform built for contractors to transform the performance of their businesses. The Company's platform provides business owners, technicians, customer service representatives and other key office staff with technology tools designed to help customers grow revenue, drive operational efficiencies, deliver a superior end-customer experience and monitor key business drivers in real-time. The Company also has subsidiaries in Yerevan, Armenia and British Columbia, Canada that primarily serve as research and development and support centers.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.